New study by Oxford University shows that taking a statin at the same time as an antidepressant leads to better treatment adherence, which may be of importance to people with depression.
An academic/industry partnership, based at the NIHR Oxford Health Biomedical Research Centre, is helping companies use experimental medicine approaches to speed up development of new drugs to treat psychiatric disorders.
Leading Oxford consultant psychiatrist Rupert McShane has responded to a new paper on the effectiveness of esketamine nasal spray, a form of ketamine, for treatment-resistant depression.
Professor Manji is one of the recipients of the 2023 Rhoda and Bernard Sarnat International Prize in Mental Health for the discovery of the rapid antidepressant effects of ketamine.
Major new study shows young people\u2019s mental health deteriorated during COVID-19, with higher levels of depression and social, emotional and behavioural difficulties than before the pandemic hit.
Oxford University and Oxford Health NHS Foundation Trust consultant psychiatrist Professor Rupert McShane is calling for ketamine to be used as an option for those patients with severe or very treatment resistant depression being considered for Electroconvulsive Therapy (ECT).
A data scientist who was able to return to work after taking medication for severe depression as part of an Oxford research trial has urged others to consider taking part in studies.
Clinical psychologist and Visiting Fellow Omid V. Ebrahimi discusses his work here in Oxford and the study he co-leads in Norway \u2013 one of the largest of its kind globally.
Young people will help create an \u2018online museum\u2019 as a way of improving their mental health, as part of a new and ground-breaking \u00a32.61m research project.
For patients with psychiatric conditions, data shows that both illness severity and instability are key factors in predicting their future risk of hospitalisation.
This new systematic review and meta-analysis of randomised controlled trials assesses the effects of statins given alone, without concomitant antidepressant treatment, in people with depressive symptoms, but who do not have a formal diagnosis of a depressive disorder.
A new summary report, What science has shown can help young people with anxiety and depression - Identifying and reviewing the 'active ingredients' of effective interventions, from Wellcome has been published. It includes new research from Oxford University, which investigates the knowns and unknowns of SSRI treatment (antidepressant drugs) in young people with depression and anxiety.
New meta-analysis, published in the Journal of the American Academy of Child & Adolescent Psychiatry, shows adolescents with depressive symptoms were more likely to engage in risky behaviours compared with non-depressed adolescents.
A new project has been awarded funding from the UKRI \u00a324 million investment into improving the mental health and wellbeing of adolescents in the UK.
![\"Graphical](\"https://www.psych.ox.ac.uk/news/taking-a-statin-at-the-same-time-of-an-antidepressant-leads-to-better-treatment-adherence-which-may-be-of-importance-to-people-with-depression/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n